Fig. 2
2D interaction of Oritavancin and the molecular targets A Cytochrome P450 3A4. B Cytochrome P450 2D6. C Cytochrome P450 2C9. D Cytochrome P450 2C19. E PI3-kinase p110-gamma subunit. F Acyl-CoA desaturase. G P-glycoprotein 1
Fig. 2 | BMC Pharmacology and Toxicology